US2022142931A1PendingUtilityA1

Multiphase soft gel capsules, apparatus and method thereof

Assignee: CATALENT ONTARIO LTDPriority: Jun 3, 2010Filed: Nov 15, 2021Published: May 12, 2022
Est. expiryJun 3, 2030(~3.9 yrs left)· nominal 20-yr term from priority
A61J 3/07A61K 31/196A61P 29/00A61P 13/08A61P 43/00A61K 9/4891A61K 9/0053A61K 9/4816A61J 3/071A61K 9/28A61K 31/4545A61J 3/077A61K 9/48A61K 45/06A61P 3/06A23P 20/10A61P 11/02A61J 3/074A61P 9/00A61P 9/12A61P 3/02A61K 9/4825
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A multi phase soft gelatin dosage form comprising at least one preformed solid dosage form and at least one liquid fill phase. The multi phase soft gelatin dosage forms of the present invention are especially useful to combine at least one solid dosage form and at least one liquid phase for single ingestion. Method and apparatus for manufacturing the multi phase soft gelatin dosage forms are also described. The solid phase, liquid phase or coatings may comprise active pharmaceutical ingredients, nutraceuticals, nutritional supplements, therapeutic substances, functional excipients or combinations thereof.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . A multi phase soft gelatin capsule for oral administration, the soft gelatin capsule comprising:
 at least one preformed solid dosage form comprising at least one active ingredient; and at least one liquid fill phase;   wherein the at least one solid dosage form and the at least one liquid fill phase are independently introduced in the soft gelatin capsule.   
     
     
         4 . The soft gelatin capsule according to  claim 3 , wherein the at least one preformed solid dosage form is a pharmaceutical grade finished dosage form. 
     
     
         5 . The soft gelatin capsule according to  claim 3 , wherein the at least one preformed solid dosage form is selected from the group consisting of a tablet, a caplet, a capsule, a slug of solid material and a granule. 
     
     
         6 . The soft gelatin capsule according to  claim 3 , wherein the at least one active ingredient in the at least one preformed solid dosage form is selected from the group consisting of: an active pharmaceutical ingredient, nutraceutical, nutritional supplement, therapeutic substance, functional excipients and combinations thereof. 
     
     
         7 . The soft gelatin capsule according to  claim 3 , wherein the at least one liquid fill phase is lipophilic or hydrophilic. 
     
     
         8 . The soft gelatin capsule according to  claim 3 , wherein the at least one liquid fill phase comprises diluent oils. 
     
     
         9 . The soft gelatin capsule according to  claim 3 , wherein the at least one liquid fill phase comprises vegetable oils, mineral oils, food grade oils, pharmaceutically acceptable oils or mixtures thereof. 
     
     
         10 . The soft gelatin capsule according to  claim 3 , wherein the at least one liquid fill phase further comprises at least one active ingredient. 
     
     
         11 . The soft gelatin capsule according to  claim 3 , wherein the at least one liquid fill phase further comprises at least one active ingredient selected from the group consisting of: an active pharmaceutical ingredient, nutraceutical, nutritional supplement, therapeutic substance, functional excipients and combinations thereof. 
     
     
         12 . The soft gelatin capsule according to  claim 3 , wherein the active pharmaceutical ingredient in the at least one preformed solid dosage form is an aspirin tablet, and wherein the at least one liquid fill phase further comprises at least one active ingredient that is Omega-3 oil. 
     
     
         13 . The soft gelatin capsule according to  claim 3 , wherein the active pharmaceutical ingredient in the at least one preformed solid dosage form is an acetaminophen tablet, and wherein the at least one liquid fill phase further comprises at least one active ingredient selected from the group consisting of: codeine, codeine phosphate, codeine sulphate, caffeine, hydrocodone, acetylsalicylic acid, pseudoephedrine hydrochloride, pseudoephedrine sulphate, brompheniramine maleate, chlorcyclizine hydrochloride, chlorpheniramine maleate, dexbrompheniramine maleate, dexchlorpheniramine maleate, diphenhydramine hydrochloride, diphenhydramine citrate, doxylamine succinate, phenindamine tartrate, pheniramine maleate, pyrilamine maleate, triprolidine hydrochloride, dextromethorphan hydrobromide, guaiphenesin, phenylephrine hydrochloride, acetaminophen and combinations thereof. 
     
     
         14 . The soft gelatin capsule according to  claim 3 , wherein the active pharmaceutical ingredient in the at least one preformed solid dosage form is an acetaminophen tablet, and wherein the at least one liquid fill phase further comprises at least one active ingredient that is acetaminophen. 
     
     
         15 . The soft gelatin capsule according to  claim 3 , wherein the active pharmaceutical ingredient in the at least one preformed solid dosage form is an ibuprofen tablet, and wherein the at least one liquid fill phase further comprises at least one active ingredient that is ibuprofen. 
     
     
         16 . The soft gelatin capsule according to  claim 3 , wherein the active pharmaceutical ingredient in the at least one preformed solid dosage form is a pseudoephedrine caplet, and wherein the at least one liquid fill phase further comprises at least one active ingredient that is loratadine. 
     
     
         17 . The soft gelatin capsule according to  claim 3 , wherein the at least one preformed solid dosage form has at least one coating. 
     
     
         18 . The soft gelatin capsule according to  claim 3 , wherein the at least one preformed solid dosage form has at least one coating selected from the group consisting of: immediate release coatings, protective coatings, enteric or delayed release coatings, sustained release coating, barrier coatings, moisture shield coatings and combinations thereof. 
     
     
         19 . The soft gelatin capsule according to  claim 3 , wherein the at least one preformed solid dosage form has at least one coating selected from the group consisting of: film coating, gelatin coating and combinations thereof. 
     
     
         20 . (canceled) 
     
     
         21 . The soft gelatin capsule according to  claim 3 , wherein the at least one preformed solid dosage form has at least one coating, the at least one coating further comprising at least one active ingredient selected from the group consisting of: an active pharmaceutical ingredient, nutraceutical, nutritional supplement, therapeutic substance, functional excipients and combinations thereof. 
     
     
         22 . (canceled) 
     
     
         23 . The soft gelatin capsule according to  claim 3 , wherein the soft gelatin capsule has at least one coating selected from the group consisting of: immediate release coatings, protective coatings, enteric or delayed release coatings, sustained release coating, barrier coatings and combinations thereof. 
     
     
         24 . (canceled) 
     
     
         25 . The soft gelatin capsule according to  claim 3 , wherein the soft gelatin capsule has at least one coating, the at least one coating further comprising at least one active ingredient selected from the group consisting of: an active pharmaceutical ingredient, nutraceutical, nutritional supplement, therapeutic substance, functional excipients and combinations thereof.

Join the waitlist — get patent alerts

Track US2022142931A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.